Genesee Valley Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-15,639
Closed -$1.63M 237
2017
Q4
$1.63M Sell
15,639
-1,004
-6% -$113K 0.68% 30
2017
Q3
$2.43M Sell
16,643
-214
-1% -$29.1K 0.99% 15
2017
Q2
$2.19M Buy
16,857
+2,200
+15% +$270K 0.93% 22
2017
Q1
$1.82K Buy
14,657
+154
+1% +$18.4K 1.25% 20
2016
Q4
$1.68K Buy
14,503
+2,096
+17% +$233K 1.18% 19
2016
Q3
$1.3M Sell
12,407
-113
-0.9% -$12.2K 0.8% 26
2016
Q2
$1.24M Buy
12,520
+329
+3% +$34K 0.8% 28
2016
Q1
$1.22M Buy
12,191
+3,371
+38% +$347K 0.82% 31
2015
Q4
$1.06M Buy
8,820
+359
+4% +$41.5K 0.69% 37
2015
Q3
$915K Buy
8,461
+44
+0.5% +$5.46K 0.61% 42
2015
Q2
$974K Sell
8,417
-634
-7% -$72.5K 0.63% 36
2015
Q1
$1.04M Buy
9,051
+137
+2% +$16.4K 0.65% 37
2014
Q4
$997K Buy
+8,914
New +$940K 0.64% 35
2014
Q1
Sell
-3,190
Closed -$270K 347
2013
Q4
$270K Buy
3,190
+48
+2% +$3.8K 0.18% 199
2013
Q3
$242K Buy
+3,142
New +$220K 0.18% 222

Other funds holding CELG

Genesee Valley Trust's CELG Position: Q1 2018 in Review

Genesee Valley Trust sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 15,639 shares — an estimated $1.63M sold.

Genesee Valley Trust first reported a position in CELG in Q3 2013 and held it in 15 quarters. The position peaked at $2.43M in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Genesee Valley Trust reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Genesee Valley Trust sold 15,639 Celgene Corp shares in Q1 2018, an estimated $1.63M.
  • Genesee Valley Trust first reported a position in Celgene Corp in Q3 2013 and held it in 15 quarters.
  • Genesee Valley Trust's Celgene Corp position peaked at $2.43M in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Genesee Valley Trust's 13F filing for Q1 2018, filed 3 Apr 2018.